Evidence map›Paper›PMID 36185100›Full record

ReviewGynecologic oncology reports2022

Patient perspectives of telemedicine in gynecologic oncology during COVID.

Christina Nestlerode, James Pavelka, Jack Basil, Kevin Schuler, Angela N Fellner, Mostafa Ghaderian, Robert Neff

Abstract readReview
In one paragraph

Review in Gynecologic oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christina NestlerodeDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
James PavelkaDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
Jack BasilDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
Kevin SchulerDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
Angela N FellnerDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
Mostafa GhaderianDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.
Robert NeffDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, TriHealth, Cincinnati, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Healthcare rapidly expanded the use of telemedicine during the COVID- 19 pandemic. Research regarding telemedicine benefits and patient perspectives during COVID are limited. The aim of this study was to determine how the pandemic impacted patient perspectives and value of telemedicine in gynecologic oncology. Methods: A cross-sectional survey was distributed to patients presenting for an appointment to the gynecologic oncology ambulatory clinic. The survey assessed patient demographics, frequency of technology use, and preferences of telemedicine use in their care. Descriptive statistics were generated and Pearson's chi square and analysis of variance (ANOVA) were used for statistical analysis. Results: 116 patients completed the survey. Respondent age range was 20-70 years old. Most respondents (80 %) had a cancer diagnosis. Nearly all (91 %) patients had access to online medical records via an online portal. Increased use of technology was not associated with agreeing to a telemedicine visit. Only 36 % stated they would feel comfortable with a telemedicine visit with a gynecologic oncologist. Patients were more willing to agree to video rather than telephone visits (41.8 % vs 24.5 %). The pandemic did not affect patient comfort level with telemedicine. Conclusions: Despite increased use and overall favorable impression, patients were not more eager to participate in telemedicine during the pandemic. Patients are open to incorporating telemedicine more often in follow up settings.

Indexed as

COVIDPandemicPatient preferencesTelehealthTelemedicine

Identifiers

PMID36185100
PMCPMC9514970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.